Evidence map›Paper›PMID 41606675›Full record

ArticleJournal of medical case reports2026

Sitosterolemia due to compound heterozygous mutations in ABCG5: a case report.

Li-Li Wu, Li Zhang, Ting-Ting Tang, Yuan-Yuan Zhou, Xin-Xia Chang, Wei Guo, Hong-Mei Yan, Huan-Dong Lin

Abstract readCase Reports
In one paragraph

Article in Journal of medical case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Li-Li Wu *Department of Endocrinology and Metabolism, Zhongshan Hospital, Fudan University, No.180 Fenglin Road, Shanghai, 200032, People's Republic of China.
Li Zhang *Department of Laboratory Medicine, Zhongshan Hospital, Fudan University, No.180 Fenglin Road, Shanghai, 200032, People's Republic of China.
Ting-Ting TangDepartment of Endocrinology and Metabolism, Zhongshan Hospital, Fudan University, No.180 Fenglin Road, Shanghai, 200032, People's Republic of China.
Yuan-Yuan ZhouDepartment of Endocrinology and Metabolism, Zhongshan Hospital, Fudan University, No.180 Fenglin Road, Shanghai, 200032, People's Republic of China.
Xin-Xia ChangDepartment of Endocrinology and Metabolism, Zhongshan Hospital, Fudan University, No.180 Fenglin Road, Shanghai, 200032, People's Republic of China.
Wei GuoDepartment of Laboratory Medicine, Zhongshan Hospital, Fudan University, No.180 Fenglin Road, Shanghai, 200032, People's Republic of China. guo.wei@zs-hospital.sh.cn.
Hong-Mei YanDepartment of Endocrinology and Metabolism, Zhongshan Hospital, Fudan University, No.180 Fenglin Road, Shanghai, 200032, People's Republic of China. yan.hongmei@zs-hospital.sh.cn.
Huan-Dong LinDepartment of Endocrinology and Metabolism, Zhongshan Hospital, Fudan University, No.180 Fenglin Road, Shanghai, 200032, People's Republic of China. lin.huandong@zs-hospital.sh.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSitosterolemia is an autosomal recessive genetic disorder characterized by hypercholesterolemia and tendon/hip xanthomas, primarily caused by pathogenic mutations in the ABCG5 or ABCG8 gene. CASE PRESENTATION: We report the clinical features and therapeutic outcomes of a 29-year-old Chinese male patient diagnosed with sitosterolemia. The patient first presented with xanthomas in childhood and subsequently developed recurrent hypercholesterolemia in adulthood. Genetic sequencing identified two distinct compound heterozygous mutations in the ABCG5 gene: c.1256G>A (p.Arg419His) and c.751C>T (p.Gln251*). Lipoprotein profiling, including targeted analysis of plant sterols (xenosterols), was performed using gas chromatography-mass spectrometry. Following poor response to statin therapy, the patient was initiated on a low-plant-sterol and low-cholesterol diet, combined with ezetimibe (an NPC1L1 inhibitor). Serum total cholesterol and low-density lipoprotein cholesterol levels normalized within 2 months of this intervention.

conclusionThis case expands the mutational spectrum of sitosterolemia and provides valuable insights for the diagnosis and clinical management of this rare disorder.

Indexed as

ATP Binding Cassette Transporter, Subfamily G, Member 5HypercholesterolemiaIntestinal DiseasesLipid Metabolism, Inborn ErrorsLipoproteinsPhytosterolsXanthomatosisAdultAnticholesteremic AgentsDiet, Fat-RestrictedEzetimibeHeterozygoteHumansMaleMutationTreatment OutcomeABCG5 protein, humanAnticholesteremic AgentsATP Binding Cassette Transporter, Subfamily G, Member 5EzetimibeLipoproteinsPhytosterolsABCG5Case reportCholesterolSitosterolemiaXenosterols

Identifiers

PMID41606675
PMCPMC12924262

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.